Julie Rubinstein $ADPT SEC Form 4 Insider Trading

Julie Rubinstein has filed a total of 6 insider trades in $ADPT since 2021. Their most recent trade was a sale of 40,044 shares, made on Mar 05, 2025. Their largest trade was a sale of 40,044 shares, made on Mar 05, 2025. We estimate that they now own 588,249 shares of $ADPT, worth an estimated $10.0 million.

Insider Trading at $ADPT

There have been a total of 163 insider trades reported at $ADPT since 2021, with 0 shares purchased and 2.4 million shares sold. The most active insider traders in $ADPT stock have been Harlan S Robins, Chad M Robins, and R Mark Adams. The most recent trade was a sale of 1,929 shares reported by KYLE PISKEL (Chief Financial Officer), made on May 16, 2025.

$ADPT Executives and Stock Owners with Insider Trades

• Harlan S Robins, Chief Scientific Officer

• Chad M Robins, CEO and Chairman

• R Mark Adams, Chief Operating Officer

• Chad M Cohen, Chief Financial Officer

• Stacy L Taylor, SVP and General Counsel

• Francis Lo, Chief People Officer

• Nitin Sood, Chief Commercial Officer, MRD

• Kyle Piskel, Principal Accounting Officer

• Tycho Peterson, Chief Financial Officer

• Kyle Piskel, Chief Financial Officer

• Sharon Benzeno, Chief Commercial Ofc Imm Med

• Julie Rubinstein, President

• Jyoti Palaniappan, SVP, Diagnostics, T-Detect

• Susan Bobulsky, Chief Commercial Officer, MRD

• Lance Baldo, Chief Medical Officer

• Julie Rubinstein, President and COO

• Sharon Benzeno, Chief Business Development Off

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.